Quarterly report pursuant to Section 13 or 15(d)

Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information (Tables)

v3.24.3
Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information (Tables)
3 Months Ended
Sep. 30, 2024
Notes Tables  
Schedule of the Consolidated Changes in Equity

Consolidated Changes in Equity (amounts in thousands)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Bio-Techne Shareholders    

    

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accumulated

​

​

​

​

​

​

​

​

​

​

Additional

​

​

​

​

Other

​

​

​

​

​

Common Stock

​

Paid-in

​

Retained

​

Comprehensive

​

​

​

​

Shares

​

Amount

​

Capital

​

Earnings

​

Income(Loss)

​

Total

Balances at June 30, 2024

 

158,216

​

$

1,582

​

$

820,337

​

$

1,325,247

​

$

(78,316)

​

$

2,068,850

Net earnings

 

​

​

​

​

​

 

​

​

 

33,600

​

 

​

​

 

33,600

Other comprehensive income (loss)

 

​

​

​

​

​

 

​

​

 

​

​

 

18,229

​

 

18,229

Common stock issued for exercise of options

 

577

​

 

6

​

 

23,224

​

 

(2,338)

​

 

​

​

 

20,892

Common stock issued for restricted stock awards

 

50

​

​

1

​

 

1

​

 

(2,646)

​

 

​

​

 

(2,644)

Cash dividends

 

​

​

​

​

​

 

​

​

 

(12,688)

​

 

​

​

 

(12,688)

Stock-based compensation expense

 

​

​

 

​

​

 

10,146

​

 

​

​

 

​

​

 

10,146

Common stock issued to employee stock purchase plan

 

35

​

​

0

​

 

2,227

​

 

​

​

 

​

​

 

2,227

Employee stock purchase plan expense

​

​

​

​

​

​

​

38

​

​

​

​

​

​

​

​

38

Balances at September 30, 2024

 

158,878

​

$

1,589

​

$

855,973

​

$

1,341,175

​

$

(60,087)

​

$

2,138,650

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Bio-Techne Shareholders    

    

  

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accumulated

​

​

​

​

​

​

​

​

​

​

Additional

​

​

​

​

Other

​

​

​

​

​

Common Stock

​

Paid-in

​

Retained

​

Comprehensive

​

​

​

​

​

Shares

​

Amount

​

Capital

​

Earnings

​

Income(Loss)

​

Total

Balances at June 30, 2023

 

157,642

​

$

1,576

​

$

721,543

​

$

1,309,461

​

$

(66,064)

​

$

1,966,516

Net earnings

 

​

​

​

​

​

 

​

​

 

50,993

​

 

​

​

 

50,993

Other comprehensive income (loss)

 

​

​

​

​

​

 

​

​

 

​

​

 

(11,952)

​

 

(11,952)

Common stock issued for exercise of options

 

633

​

 

6

​

 

12,877

​

 

(15,460)

​

 

​

​

 

(2,577)

Common stock issued for restricted stock awards

 

47

​

​

1

​

 

0

​

 

(4,768)

​

 

​

​

 

(4,767)

Cash dividends

 

​

​

​

​

​

 

​

​

 

(12,654)

​

 

​

​

 

(12,654)

Stock-based compensation expense

 

​

​

 

​

​

 

9,981

​

 

​

​

 

​

​

 

9,981

Common stock issued to employee stock purchase plan

 

33

​

​

1

​

 

2,093

​

 

​

​

 

​

​

 

2,094

Employee stock purchase plan expense

​

​

​

​

​

​

​

112

​

​

​

​

​

​

​

​

112

Balances at September 30, 2023

 

158,355

​

$

1,584

​

$

746,606

​

$

1,327,572

​

$

(78,016)

​

$

1,997,746

Schedule of changes in Accumulated Other Comprehensive Income (Loss)

​

​

​

​

​

​

​

​

​

​

​

Three months ended September 30, 2024 (in thousands):

​

Unrealized

​

​

​

​

​

​

​

​

Gains

​

Foreign 

​

​

​

​

​

(Losses) on

​

Currency

​

​

​

​

​

Derivative

​

Translation 

​

​

​

​

    

Instruments

    

Adjustments

    

Total

Balance as of June 30, 2024, net of tax

​

$

8,102

​

$

(86,418)

​

$

(78,316)

Other comprehensive income (loss), before tax:

​

​

​

​

​

​

​

​

​

Amounts before reclassifications

​

​

(5,010)

​

​

20,659

​

​

15,649

Amounts reclassified out

​

​

2,599

​

​

782

​

​

3,381

Total other comprehensive income (loss), before tax

​

​

(2,411)

​

​

21,441

​

​

19,030

Tax (expense)/benefit

​

​

(616)

​

​

(185)

​

​

(801)

Total other comprehensive income (loss), net of tax

​

 

(3,027)

​

​

21,256

​

​

18,229

Balance as of September 30, 2024, net of tax

​

$

5,075

​

$

(65,162)

​

$

(60,087)

​

​

​

​

​

​

​

​

​

​

​

Three months ended September 30, 2023 (in thousands):

​

Unrealized

​

​

​

​

​

​

​

​

Gains

​

Foreign 

​

​

​

​

​

(Losses) on

​

Currency

​

​

​

​

​

Derivative

​

Translation 

​

​

​

​

    

Instruments

    

Adjustments

    

Total

Balance as of June 30, 2023 net of tax:

​

$

12,862

​

$

(78,926)

​

$

(66,064)

Other comprehensive income (loss), before tax:

​

​

​

​

​

​

​

​

​

Amounts before reclassifications

​

​

1,587

​

​

(11,069)

​

​

(9,482)

Amounts reclassified out

​

​

(2,539)

​

​

(698)

​

​

(3,237)

Total other comprehensive income (loss), before tax

​

​

(952)

​

​

(11,767)

​

​

(12,719)

Tax (expense)/benefit

​

​

(602)

​

​

(165)

​

​

(767)

Total other comprehensive income (loss), net of tax

​

 

(350)

​

​

(11,602)

​

​

(11,952)

Balance as of September 30, 2023, net of tax

​

$

12,512

​

$

(90,528)

​

$

(78,016)